ArticleBMC infectious diseases2025
Malaria and typhoidal co-infection among febrile patients: a health facility-based cross-sectional study in Northern Ghana.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMalaria and typhoid fever constitute a significant public health burden in developing countries, often traced to a common predisposing factor such as poverty and poor water, sanitation, and hygiene (WASH) practices. This study investigated the prevalence of malaria, typhoid fever, their co-infection and associated factors among febrile patients in the Kassena Nankana Municipal and Nabdam Districts of the Upper East Region, Ghana.
methodsA health facility-based cross-sectional study was conducted in seven selected health facilities in the two districts in the Upper East Region of Ghana during peak rainy seasons (July to November) in 2023 and 2024. After informed consent documentation, a total of 332 febrile patients were recruited. Sociodemographic and clinical information of participants was obtained using a structured questionnaire. A finger prick capillary blood sample was collected for malaria antigen rapid test and typhoid fever IgM antibody serology.
resultsThe prevalence of febrile patients with either malaria, typhoid fever or both was 60.0%. The seroprevalence of malaria and typhoid fever was 37.7% and 36.7%, respectively, with a 14.7% co-infection rate. The Nabdam district was associated with increased odds of malaria (adjusted odds ratio (aOR) = 3.87; 95%CI: [1.71–8.76]; p < 0.01), while a tertiary education background was significantly associated with increased odds of typhoid fever (aOR = 5.33; 95%CI: [1.20–23.72]; p = 0.03). The use of a tap water source was associated with reduced odds of typhoid fever (aOR = 0.36; 95%CI: [0.15–0.87]; p = 0.02) and malaria-typhoid fever co-infection (aOR = 0.07; 95%CI: [0.01–0.60]; p = 0.02). Febrile patients presenting with vomiting were a predictor of malaria (aOR = 2.45; 95%CI: [1.36–4.40]; p < 0.01).
conclusionOur study found high prevalence of malaria (37.7%), typhoid fever (36.7%), and their co-infection (14.7%) among febrile patients in the Upper East Region of Ghana. These rates exceed national averages and highlight persistent regional disparities, underscoring the need for integrated diagnostic and treatment strategies for febrile illnesses in the region. Our study also shows that malaria risk was higher in Nabdam district, tertiary education was associated with increased typhoid fever risk, and tap water use reduced odds of typhoid fever and malaria-typhoid co-infection, highlighting the need for targeted interventions addressing these factors. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.